-
Mashup Score: 0Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a TP53-Dependent Manner - 1 year(s) ago
This study identifies the repetitive element targets of epigenetic therapies in ovarian carcinoma and indicates a role for p53 in this process.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics - 1 year(s) ago
AbstractPurpose:. Tumor antigens are central to antitumor immunity. Recent evidence suggests that peptides from noncanonical (nonC) aberrantly translated proteins can be presented on HLA-I by tumor cells. Here, we investigated the immunogenicity of nonC tumor HLA-I ligands (nonC-TL) to better understand their contribution to cancer immunosurveillance and their therapeutic…
Categories: General Medicine News, Latest HeadlinesTweet-
Non-canonical proteins as candidate targets for ##cancerimmunotherapy https://t.co/we8nexFBrD https://t.co/hbCKdGUtYt
-
-
Mashup Score: 0Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a TP53-Dependent Manner - 1 year(s) ago
This study identifies the repetitive element targets of epigenetic therapies in ovarian carcinoma and indicates a role for p53 in this process.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Dr. @ChiappinelliLab talks about pursuing future research in this exciting area and offers career advice for other early career researchers. https://t.co/lIiDWGo3HO @GWSMHS @GWCancer #OvarianCancer #CancerImmunotherapy https://t.co/IaxByRYR0A https://t.co/c2BtJu3MPw
-
-
Mashup Score: 1Conferences | Keystone Symposia - 1 year(s) ago
Privacy Policy Terms of Use © 2023 Keystone Symposia on Molecular and Cellular Biology | Registered 501(c)(3). EIN: 84-1326605
Source: www.keystonesymposia.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Register now for On Demand Access to @KeystoneSymp #CancerImmunotherapy: Mechanisms of Response versus Resistance, this March! https://t.co/uRk1Yo2NWZ #KSCancerImmuno23 https://t.co/oa7UObAmDf https://t.co/Uj9s5CcCIB NRC is going to be there virtually! 😀
-
-
Mashup Score: 0Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a TP53-Dependent Manner - 1 year(s) ago
This study identifies the repetitive element targets of epigenetic therapies in ovarian carcinoma and indicates a role for p53 in this process.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Dr. @ChiappinelliLab talks about pursuing future research in this exciting area and offers career advice for other early career researchers. https://t.co/lIiDWGo3HO @GWSMHS @GWCancer #OvarianCancer #CancerImmunotherapy https://t.co/YoMFzQIt9E https://t.co/Fk3HJLR1q8
-
-
Mashup Score: 0
Immunotherapy has transformed the treatment landscape for cancer, leading to durable remissions in patients with previously refractory disease. The promise of these treatments is limited by inflammatory toxicities that can target any system in the body. Gastrointestinal toxicities, in particular colitis and enterocolitis, are the most common severe toxicities induced by cancer immunotherapy and…
Source: ZoomCategories: Gastroenterology, Latest HeadlinesTweet-
Register for the Monday, Jan. 9 #GastroBites session to learn about the causes of #gastrointestinal toxicities induced by #cancerimmunotherapy, the optimal workup and available treatment modalities. https://t.co/fXg0ggcDVr #GITwitter https://t.co/V0z9Z2B9Yo
-
-
Mashup Score: 2Caleb Lareau - 1 year(s) ago
Caleb Lareau describes his life, only half jokingly, as a “Silicon Valley meme.” Within a few months of moving to Palo Alto, Calif. in the summer of 2020
Source: STATCategories: Latest Headlines, Oncologists1Tweet-
Congratulations to Stanford’s Caleb Lareau on being named a 2022 @statnews Wunderkind. Lareau and his mentor SCI member Ansu Satpathy study #CancerImmunotherapy. https://t.co/8PBrv6f61M @CalebLareau @Satpathology
-
-
Mashup Score: 3cAttendee - 1 year(s) agoSource: cattendee.abstractsonline.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
#ESMOImmuno22 kicked off today 🙌 For those who are attending, either onsite (Geneva) or online, don’t forget to have a look at your congress bag to browse and download exclusive content for the event 👇 https://t.co/cQHZtVU6iM #immunotherapies #cancerimmunotherapy https://t.co/nsUHysDW4Q
-
-
Mashup Score: 0Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a TP53-Dependent Manner - 2 year(s) ago
This study identifies the repetitive element targets of epigenetic therapies in ovarian carcinoma and indicates a role for p53 in this process.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Dr. @ChiappinelliLab talks about pursuing future research in this exciting area and offers career advice for other early career researchers. https://t.co/lIiDWGo3HO @GWSMHS @GWCancer #OvarianCancer #CancerImmunotherapy https://t.co/SqtEwfzyzz https://t.co/p3STxUj7N2
-
-
Mashup Score: 2Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a TP53-Dependent Manner - 2 year(s) ago
This study identifies the repetitive element targets of epigenetic therapies in ovarian carcinoma and indicates a role for p53 in this process.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Dr. @ChiappinelliLab talks about pursuing future research in this exciting area and offers career advice for other early career researchers. https://t.co/lIiDWGoBxm @GWSMHS @GWCancer #OvarianCancer #CancerImmunotherapy https://t.co/cnAeZlxgJB
-
Dr. @ChiappinelliLab talks about pursuing future research in this exciting area and offers career advice for other early career researchers. https://t.co/lIiDWGo3HO @GWSMHS @GWCancer #OvarianCancer #CancerImmunotherapy https://t.co/p7K3q0PkSN https://t.co/t9B7fP9eNh